Factors affecting the choice of drospirenone as the component of combined contraceptive pill in daily clinical practice: the results of nation-wide survey

Objectives: The aim of the multicenter, open-label, post-marketing, observational survey was to assess doctors’ preferences in choosing progestogen component combined contraceptive pill (CCP) and factors affecting this choice daily clinical practice as well non-contraceptive reasons use CCP containing drospirenone (CCPD) patients’ tolerance satisfaction with treatment. Material methods: This performed nation-wide participation 222 doctors involving 10,345 patients treated CCPD. study questionnaire included questions concerning a assessing prescription pattern drug Results: frequently declared their CCP. most important drospirenone, by doctors, were level, consistent regulation menstrual cycle not causing spotting. CCPD prescribed irregular cycles (62.7%) painful menstruation (46.8%). During follow-up, significantly increased percentage assessed treatment very good (52.5% vs 68.0%; p < 0.01) satisfied its (61.9% 77.8%, 0.01). Conclusions: 1) Drospirenone is chosen Polish gynecologists due tolerance, no spotting opinion. 2) used menstruation. 3) tolerated.